Search
For more relevant search experience, click Advance Search | Save search | Saved Searches
Reset all
Publication Type
Availability
  • Content type: Complimentary
  • Content type: Free
  • Content type: Open Access
  • Content type: Purchased
  • Content type: To Purchase
Languages
Publisher
Subject
Author(s)
Show more ...
Mastocytosis-derived extracellular vesicles deliver miR-23a and miR-30a into pre-osteoblasts and prevent osteoblastogenesis and bone formation
Do-Kyun Kim, Geethani Bandara, Young-Eun Cho, Hirsh D. Komarow, Danielle R. Donahue, Baktiar Karim, Moon-Chang Baek, Ho Min Kim, Dean D. Metcalfe, Ana Olivera
Publication Date:
Article Pages: 1 Open access contents
Ruxolitinib withdrawal due to the COVID-19
Marko Lucijanic, Rajko Kusec
Publication Date:
Article Pages: 1 Open access contents
Response to: Ruxolitinib withdrawal due to the COVID-19
Tiziano Barbui, Alessandra Carobbio
Publication Date:
Article Pages: 1 Open access contents
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm
Richard A. Salisbury, Natalia Curto-Garcia, Jennifer O’Sullivan, Frederick Chen, Paolo Polzella, Anna L. Godfrey, James Russell, Steven Knapper, John Willan, Rebecca Frewin, Shivani Joshi, Siamak Arami, Sarah Burns, Chun Huat Teh, Frances Wadelin, Jaymathi Dhanapal, Pratap Neelakantan, Dragana Milojkovic, Beth Psaila, Richard Szydlo, Sebastian Francis, Catherine Cargo, Manish Jain, Andrew McGregor, Louise Wallis, Andrew Duncombe, Hayder Hussein, Peter Dyer, Laura Munro, Lee Bond, Mary Frances McMullin, Tim C. P. Somervaille, Mamta Garg, Mallika Sekhar, Claire Harrison, Adam J. Mead, Andrew J. Innes
Publication Date:
Article Pages: 6 Open access contents
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib
Tiziano Barbui, Alessandro Maria Vannucchi, Alberto Alvarez-Larran, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Alberto Ferrari, Giuseppe Rossi, Elena Elli, Marcio Miguel Andrade-Campos, Mercedes Gasior Kabat, Jean-Jaques Kiladjian, Francesca Palandri, Giulia Benevolo, Valentin Garcia-Gutierrez, Maria Laura Fox, Maria Angeles Foncillas, Carmen Montoya Morcillo, Elisa Rumi, Santiago Osorio, Petros Papadopoulos, Massimiliano Bonifacio, Keina Susana Quiroz Cervantes, Miguel Sagues Serrano, Gonzalo Carreno-Tarragona, Marta Anna Sobas, Francesca Lunghi, Andrea Patriarca, Begona Navas Elorza, Anna Angona, Elena Magro Mazo, Steffen Koschmieder, Marco Ruggeri, Beatriz Cuevas, Juan Carlos Hernandez-Boluda, Emma Lopez Abadia, Blanca Xicoy Cirici, Paola Guglielmelli, Marta Garrote, Daniele Cattaneo, Rosa Daffini, Fabrizio Cavalca, Beatriz Bellosillo, Lina Benajiba, Natalia Curto-Garcia, Marta Bellini, Silvia Betti, Valerio De Stefano, Claire Harrison, Alessandro Rambaldi
Publication Date:
Article Pages: 8 Open access contents
Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis
Moshe Talpaz, Jean-Jacques Kiladjian
Publication Date:
Article Pages: 16 Open access contents
Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea
Alberto Alvarez-Larrán, Alvaro Díaz-González, Esperanza Such, Elvira Mora, Marcio Andrade-Campos, Carmen García-Hernández, M. Teresa Gómez-Casares, Valentín García-Gutiérrez, Gonzalo Carreño-Tarragona, Marta Garrote, Lierni Fernández-Ibarrondo, José Cervera, Beatriz Bellosillo, Francisco Cervantes, Juan Carlos Hernández-Boluda
Publication Date:
Article Pages: 4 Open access contents